Benchmark raised the firm’s price target on Green Thumb Industries (GTBIF) to $8 from $7 and keeps a Buy rating on the shares after the company reported Q2 results and guided for Q3 revenue to be flat to down low-single digits if Minnesota’s adult-use launch does not occur in the quarter. The firm expects investor focus to center on adult-use expansion in Minnesota, Pennsylvania, and Virginia, competitive share gains in core states, and execution in the near-term, the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBIF:
- Trump debates on reclassifying marijuana as less dangerous drug, WSJ says
- Green Thumb Industries Navigates Growth and Challenges in Latest Earnings Call
- Green Thumb Industries Reports Q2 2025 Financial Results
- U.S. House okays amendment on VA cannabis recommendations, Marijuana Herald says
- Green Thumb Industries Shareholders Approve Key Governance Changes